Important notice regarding Rhopressa

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading

Florida Jurisprudence CE Requirement

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading

Important Notice Regarding Inveltys

The Board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents Continue reading

Important notice regarding Cequa

The board approved Cequa (cyclosporine) 0.09% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Cequa. Continue reading

Board Meeting Registration for Florida Jurisprudence Credit

You may now register to attend a disciplinary board meeting for the purposes of receiving credit for Florida Jurisprudence continuing education. To Register, please click Here Continue reading

Temporary Delay in Printing of Licenses

We are currently experiencing a temporary delay in printing and mailing the hard copy of your license. Please click here for more information. Continue reading

Board Chairs/Vice Chairs Annual Long-range Planning Meeting

The Annual Long Range Planning meeting has been scheduled for Friday, May 31, 2019. Please click here for more information. Continue reading

Rule 64B13-5.001 Hours Requirement

If you are seeking Florida jurisprudence CE credits for attending a disciplinary hearing please see the meeting site information for the upcoming February 8, 2019 board meeting. Continue reading

Annual Report & Long-Range Plan Released for the 2017-2018 Fiscal Year

The Annual Report & Long-Range Plan for the 2017-2018 Fiscal Year is now available to view online. Continue reading

Important Information Regarding Cequa

During the September 28, 2018 Board of Optometry meeting, the board approved for addition to the Formulary of Topical Ocular Pharmaceutical Agents the ophthalmic solution Cequa. Continue reading